BELIDOR
LIVE

Serial Number

79386545

Owner

Albador GmbH

Attorney

Andrew D. Bochner

Filing Date

Aug 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BELIDOR Trademark

Serial Number: 79386545 • Registration: 7998229

BELIDOR is a trademark filed by Albador GmbH on August 2, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Albador GmbH (2 trademarks)

Viktringer Ring 26

Entity Type: 99

Trademark Details

Filing Date

August 2, 2023

Registration Date

October 28, 2025

Published for Opposition

September 9, 2025

Goods & Services

Cereal bars; cereal-based energy bars; aromatic preparations for food, namely, spices

Cosmetics; beauty care preparations, namely, non-medicated skin care preparations; cosmetic creams; skin soap; perfumery, essential oils, hair lotions; dentifrices; skincare cosmetics; cosmetic preparations for slimming purposes; beauty masks; creams, namely, skin creams; shaving creams; body creams; eye creams; base creams being make-up primers; face creams for cosmetic use; hand creams; nail creams; cuticle creams; suntan lotion; cold cream; lip cream; skin creams; hair creams; aromatherapy skin creams; skin cleansing creams; depilatory creams; skin washing creams; exfoliant creams; body mask cream; anti-aging creams; anti-freckle creams; skin creams, namely, non-medicated skin care preparations; toilet preparations, namely, toilet waters; laundry detergents

Mineral and aerated waters and other non-alcoholic beverages, namely, drinking water; fruit juice beverages; syrups for making non-alcoholic fruit juice beverages; energy drink; non-alcoholic beverages, namely, soft drinks; aperitifs, non-alcoholic; non-alcoholic essences for making non-alcoholic beverages, not in the nature of essential oils

Advertising; business management; business administration; office functions; secretarial services; business information; procurement services for others, namely, purchasing of skin care preparations for others; business efficiency expert services; professional business consultancy; marketing services; marketing research

Pharmaceutical and veterinary preparations for the use in the treatment of impaired joint mobility; pharmaceutical and veterinary preparations for the use in improving and maintaining cognitive function; pharmaceutical and veterinary preparations for the use in improving blood flow; pharmaceutical and veterinary preparations for the use in improving concentration; pharmaceutical and veterinary preparations for the use in maintaining normal blood cholesterol; pharmaceutical and veterinary preparations for the use in treatment of skin disorders; pharmaceutical and veterinary preparations for the use in treatment of diabetes; pharmaceutical and veterinary preparations for the use in blood sugar regulation; pharmaceutical and veterinary preparations for the use in treatment of cold and flu; pharmaceutical and veterinary preparations for the use in improving muscle recovery and endurance; pharmaceutical and veterinary preparations for the use in improving immune system; sanitary preparations for medical purposes; dietetic preparations for medical or veterinary use; infant formula; dietary supplements for humans and animals; medical and surgical plasters, materials for dressings, namely bandages; disinfectants; medicated skin care preparations featuring an active substance derived from silver fir wood, for medical use; pharmaceutical preparations for the use in treatment of impaired joint mobility; pharmaceutical preparations for the use in improving and maintaining cognitive function; pharmaceutical preparations for the use in improving blood flow; pharmaceutical preparations for the use in improving concentration; pharmaceutical preparations for the use in maintaining normal blood cholesterol; pharmaceutical preparations for the use in treatment of diabetes; pharmaceutical preparations for the use in blood sugar regulation; pharmaceutical preparations for the use in treatment of cold and flu; pharmaceutical preparations for the use in improving muscle recovery and endurance; pharmaceutical preparations for the use in improving immune system; medical preparations for the use in treatment of impaired joint mobility; medical preparations for the use in improving and maintaining cognitive function; medical preparations for the use in improving blood flow; medical preparations for the use in improving concentration; medical preparations for the use in maintaining normal blood cholesterol; pharmaceutical preparations for the use in treatment of skin disorders; medical preparations for the use in treatment of diabetes; medical preparations for the use in blood sugar regulation; medical preparations for the use in treatment of cold and flu; medical preparations for the use in improving muscle recovery and endurance; medical preparations for the use in improving immune system; pills for use in the treatment of cardiovascular disorders, dermatological disorders, skin disorders, diabetes, cholesterol, and loss in mental concentration; antioxidant pills being food supplements; food supplements; capsules for use in the treatment of cardiovascular disorders, dermatological disorders, skin disorders, diabetes, cholesterol, and loss in mental concentration; pharmaceutical skin creams; medicated skin creams; medicated face cream; medicated body creams; pain relieving creams; medicated protective skin creams; medical therapeutic skin creams; medicated moisturising skin creams; pharmaceutical preparations, namely acne creams; cold cream for medical use; hand creams for medical use; medicated creams for the feet; medicated creams for the lips; skin care creams for medical use; anti-fungal creams for medical purposes; medicated creams for application after exposure to the sun; capsules for medicines for use in the treatment of cardiovascular disorders, dermatological disorders, skin disorders, diabetes, cholesterol, and loss in mental concentration; cachets for pharmaceutical purposes, being capsules for the use in treatment of impaired joint mobility; cachets for pharmaceutical purposes, being capsules for the use in improving and maintaining cognitive function; cachets for pharmaceutical purposes, being capsules for the use in improving blood flow; cachets for pharmaceutical purposes, being capsules for the use in improving concentration; cachets for pharmaceutical purposes, being capsules for the use in maintaining normal blood cholesterol; cachets for pharmaceutical purposes, being capsules for the use in treatment of skin disorders; cachets for pharmaceutical purposes, being capsules for the use in treatment of diabetes; cachets for pharmaceutical purposes, being capsules for the use in blood sugar regulation; cachets for pharmaceutical purposes, being capsules for the use in treatment of cold and flu; cachets for pharmaceutical purposes, being capsules for the use in improving muscle recovery and endurance; cachets for pharmaceutical purposes, being capsules for the use in improving immune system; dental, medical and surgical preparations for use in the treatment of cardiovascular disorders, dermatological disorders, skin disorders, diabetes, cholesterol, and loss in mental concentration; vitamin supplements; amino acid dietary supplements; anti-oxidant food supplements; nutritional supplements; mineral food supplements; vitamin preparations; food supplements for dietetic use; herbal extracts, other than essential oils, for medical purposes; medicinal drinks; dietary fibre for treating constipation; candy, medicated; medicated candies; food supplements comprising by-products of the processing of cereals for dietetic or medical purposes; medicinal oils, other than essential oils; medicinal herbs; medicinal tea; amino acids for medical purpose

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 6, 2026 FICS
FINAL DISPOSITION PROCESSED
May 6, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 28, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 6, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 6, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 6, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 6, 2025 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 31, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 24, 2025 PBCR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2025 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 31, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 31, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 31, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 31, 2025 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2024 TROA
REFUSAL PROCESSED BY IB
May 22, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 9, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 2, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 28, 2023 REPR